JUN 11, 2015
OIG to Scrutinize ‘Questionable Billing,’ Open Payments, Generic Drugs Pricing
Ophthalmologists’ 2012 “questionable billing,” Open Payments reports and generic drug pricing will get closer government scrutiny. Health and Human Services’ Inspector General Daniel Levinson announced the review in a mid-year update to his office’s annual work plan.